| Q34600532 | "Janus" cyclic peptides: a new approach to amyloid fibril inhibition? |
| Q33373345 | AA-amyloidosis can be transferred by peripheral blood monocytes |
| Q42772096 | AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences |
| Q37690331 | ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review |
| Q30395060 | Aberrant protein structure and diseases of the brain |
| Q57259399 | Abstracts |
| Q37156874 | Acute phase reactants as novel predictors of cardiovascular disease |
| Q58295411 | Additional evidence that the fibril amyloid-related proteins share local regions of amino acid sequence similarity |
| Q33991820 | Age-dependent increase in thiol conjugated forms of transthyretin (TTR) in the elderly: quantitative analyses by the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) protein chip system. |
| Q21136371 | Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome |
| Q46150302 | Amyloid and amyloidoses |
| Q34147275 | Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis |
| Q46502103 | Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines |
| Q51517480 | Amyloid goiter and hypopituitarism in a patient with systemic amyloidosis. |
| Q50541599 | Amyloid-like fibrils are not detected in non-small cell lung cancer tissue samples. |
| Q36719211 | Amyloidogenic peptides of yeast cell wall glucantransferase Bgl2p as a model for the investigation of its pH-dependent fibril formation |
| Q36898656 | Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy |
| Q36498412 | Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience |
| Q54998184 | An unusual etiology of plummer-Vinson syndrome. |
| Q37560167 | Animal models of human amyloidoses: are transgenic mice worth the time and trouble? |
| Q36285865 | Application of confocal laser scanning microscopy for the diagnosis of amyloidosis |
| Q34143076 | Atypical presentation of atypical amyloid |
| Q46433557 | Bence-Jones protein-type myeloma with amyloid myopathy presenting as amyloidomas and extensive amyloid deposits in the muscularis propria: a rapidly fatal autopsy case |
| Q28393352 | Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status |
| Q51153147 | Cardiac amyloidosis as a potential risk factor for transapical transcatheter aortic valve implantation. |
| Q37238951 | Cerebral amyloid angiopathy-related hemorrhages |
| Q36136387 | Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. |
| Q26865114 | Cervical lymph node diseases in children |
| Q42934740 | Characterizing the assembly of the Sup35 yeast prion fragment, GNNQQNY: structural changes accompany a fiber-to-crystal switch. |
| Q33622192 | Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement |
| Q84613327 | Coagulopathy in a patient with nephrotic syndrome |
| Q43076154 | Competition between intramolecular and intermolecular interactions in an amyloid-forming protein |
| Q45759393 | Confirmation of local amino acid sequence homology between human prolactin and the amyloid-related proteins. |
| Q27666683 | Conformational Conversion during Amyloid Formation at Atomic Resolution |
| Q35001154 | Cooperative stabilization of transthyretin by clusterin and diflunisal. |
| Q36286068 | Corruption and spread of pathogenic proteins in neurodegenerative diseases |
| Q37602130 | Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease |
| Q41814084 | Development and evaluation of agents for targeting visceral amyloid |
| Q48286557 | Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes |
| Q33654101 | Diagnosis and typing of systemic amyloidosis: The role of abdominal fat pad fine needle aspiration biopsy |
| Q28547692 | Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures |
| Q43201255 | Early aggregation preceding the nucleation of insulin amyloid fibrils as monitored by small angle X-ray scattering. |
| Q38282186 | Emerging treatments for amyloidosis |
| Q47727255 | Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system |
| Q36524933 | Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea |
| Q43197716 | Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation |
| Q33479158 | Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model |
| Q37349941 | Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy |
| Q45025140 | Fibrinogen A alpha-chain amyloidosis: report of the first case in Latin America |
| Q57944846 | From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy |
| Q37477467 | Glimpses of the molecular mechanisms of beta2-microglobulin fibril formation in vitro: aggregation on a complex energy landscape |
| Q53296077 | Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant – ΔK58-β2m |
| Q34007478 | Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases. |
| Q37784314 | Heparan Sulfate Proteoglycans in Amyloidosis |
| Q26744469 | Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting |
| Q28482893 | Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity |
| Q27649069 | Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins |
| Q46782390 | Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides |
| Q46222348 | In vitro binding of [³H]PIB to human amyloid deposits of different types |
| Q31106882 | Incidence and survival in non-hereditary amyloidosis in Sweden |
| Q61813463 | Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State |
| Q54454022 | Isolation and characterization of monoclonal antibodies against bovine serum amyloid A1 protein. |
| Q58544495 | Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan |
| Q50692610 | Left Ventricular Torsion by Two-Dimensional Speckle Tracking Echocardiography in Patient with A-Type Amyloid Heart Disease |
| Q41029054 | Light and heat control over secondary structure and amyloid-like fiber formation in an overcrowded-alkene-modified Trp zipper |
| Q83462804 | Light-triggered aggregation and disassembly of amyloid-like structures |
| Q42110148 | Localized mediastinal amyloidosis: A misnomer? |
| Q30470300 | Localized tongue Amyloidosis in a Patient with Neurofibromatosis type II. |
| Q38027941 | Luminescent conjugated poly- and oligo-thiophenes: optical ligands for spectral assignment of a plethora of protein aggregates |
| Q42550081 | Magic angle spinning NMR analysis of beta2-microglobulin amyloid fibrils in two distinct morphologies |
| Q52847877 | Mass spectrometry and the amyloid problem--how far can we go in the gas phase? |
| Q35133371 | Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs |
| Q40298684 | Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report. |
| Q21563394 | Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase |
| Q53300132 | Morphology and aggregation of RADA-16-I peptide Studied by AFM, NMR and molecular dynamics simulations. |
| Q33587490 | Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity |
| Q40188133 | Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study |
| Q26751000 | Neuroendocrine hormone amylin in diabetes |
| Q39024208 | New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis |
| Q28728135 | Nonhuman primate models of Alzheimer-like cerebral proteopathy |
| Q36275424 | Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis |
| Q26749061 | Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds |
| Q58265728 | Pathogenesis of experimental amyloid protein A amyloidosis in sore hocks-affected rabbits |
| Q33918726 | Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils |
| Q34140067 | Prion-like aggregates: infectious agents in human disease |
| Q37722588 | Protein folding and aggregation in bacteria |
| Q89737010 | Rare amyloidoma of the tongue base: A case report and review of the literature |
| Q58030096 | Reasoning with Effects of Clinical Guideline Actions Using OWL: AL Amyloidosis as a Case Study |
| Q37292040 | Review. Reflections on amyloidosis in Papua New Guinea |
| Q54107799 | Revisiting renal amyloidosis with clinicopathological characteristics, grading, and scoring: A single-institutional experience. |
| Q42048047 | Ribonuclease A suggests how proteins self-chaperone against amyloid fiber formation |
| Q58772744 | Right Atrial Deformation Analysis in Cardiac Amyloidosis - Results from the Three-Dimensional Speckle-Tracking Echocardiographic MAGYAR-Path Study |
| Q37459593 | Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis |
| Q37285515 | Short protein segments can drive a non-fibrillizing protein into the amyloid state |
| Q37450061 | Small organic probes as amyloid specific ligands--past and recent molecular scaffolds |
| Q45867751 | Somatic mosaicism with reversion to normality of a mutated transthyretin allele related to a familial amyloidotic polyneuropathy |
| Q30359467 | Stepwise organization of the β-structure identifies key regions essential for the propagation and cytotoxicity of insulin amyloid fibrils. |
| Q33597057 | Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy |
| Q27670453 | Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation |
| Q58182330 | Surgical removal of amyloid-laden lymph nodes: a possible therapeutic approach in a primary systemic AL amyloidosis patient with focal lymphadenopathy |
| Q35106783 | Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ |
| Q46865930 | Synthesis and evaluation of antineurotoxicity properties of an amyloid-β peptide targeting ligand containing a triamino acid |
| Q38085664 | Systemic amyloidoses |
| Q33735246 | Telocytes in human isolated atrial amyloidosis: ultrastructural remodelling |
| Q42151789 | The S100B/RAGE Axis in Alzheimer's Disease |
| Q27667880 | The amyloid-Congo red interface at atomic resolution |
| Q46510099 | The conformation of the Congo-red ligand bound to amyloid fibrils HET-s(218-289): a solid-state NMR study |
| Q37409163 | The multiple mechanisms of amyloid deposition: the role of parkin |
| Q38074867 | The skin: a mirror to the gut. |
| Q27650826 | The structure of a fibril-forming sequence, NNQQNY, in the context of a globular fold |
| Q30514124 | Toxic fibrillar oligomers of amyloid-β have cross-β structure |
| Q42944341 | Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes |
| Q58285971 | Transthyretin-derived amyloid deposition in the heart of an elderly Japanese population |
| Q37755977 | Transthyretin-related amyloidoses and the heart: a clinical overview |
| Q36763960 | Transthyretin: the servant of many masters. |
| Q57445076 | Understanding and Ameliorating the TTR Amyloidoses |
| Q84564606 | Unusual cause of proteinuria and re-renal failure after kidney transplantation: de novo localized AL amyloidosis in renal allograft |
| Q36366356 | Updates in cardiac amyloidosis: a review. |
| Q33778710 | Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-associated amyloidosis |
| Q34496831 | Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis |
| Q35205226 | Water molecular system dynamics associated with amyloidogenic nucleation as revealed by real time near infrared spectroscopy and aquaphotomics |
| Q50597319 | [Amyloid centers in Europe: the EURAMY project]. |
| Q83409267 | [Amyloidosis of the heart] |
| Q84564171 | [Update on immunohistological classification of amyloidoses] |
| Q37573510 | beta(2)-microglobulin: from physiology to amyloidosis |
| Q58582669 | β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage |